肝细胞SH3RF2缺陷是NAFLD的关键加重因素
本研究探讨E3连接酶SH3RF2在NAFLD中的作用及机制。在NAFLD小鼠、猴子和临床个体中SH3RF2均受抑制;肝细胞SH3RF2缺陷显著加重脂质蓄积,机制为SH3RF2直接结合ATP柠檬酸裂解酶并促进其K48连接泛素化降解,导致乙酰辅酶A积累、新生脂肪生成增强和脂质沉积。SH3RF2耗竭是NAFLD进展的关键加重因素,是有前景的治疗靶点。
要点
- NAFLD小鼠、猴子和临床个体中SH3RF2表达均受抑制。
- 肝细胞SH3RF2缺陷加重培养肝细胞和饮食诱导NAFLD小鼠的脂质蓄积。
- SH3RF2通过促进ATP柠檬酸裂解酶K48泛素化降解抑制脂肪生成。
核心结论
- 肝细胞SH3RF2耗竭是NAFLD进展的关键加重因素,是有前景的治疗靶点。
研究设计与样本
- 研究检测NAFLD小鼠、猴子和临床个体中SH3RF2表达,并使用基因中断模型在培养肝细胞和饮食诱导NAFLD小鼠中验证肝细胞SH3RF2缺陷的作用。
主要发现
- NAFLD状态下小鼠、猴子和临床个体SH3RF2受抑制。
- 肝细胞SH3RF2缺陷显著加重培养肝细胞和饮食诱导NAFLD小鼠的脂质蓄积。
- SH3RF2直接结合ATP柠檬酸裂解酶并促进其K48连接泛素化依赖性降解。
- Sh3rf2敲除肝细胞和肝脏中乙酰辅酶A较野生型对照显著积累,导致新生脂肪生成、胆固醇产生和脂质沉积增强。
临床怎么用
- SH3RF2可作为NAFLD及相关肝病潜在治疗靶点,但尚需临床研究验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: NAFLD has become the most common liver disease worldwide but lacks a well-established pharmacological therapy. Here, we aimed to investigate the role of an E3 ligase SH3 domain-containing ring finger 2 (SH3RF2) in NAFLD and to further explore the underlying mechanisms. METHODS AND RESULTS: In this study, we found that SH3RF2 was suppressed in the setting of NAFLD across mice, monkeys, and clinical individuals. Based on a genetic interruption model, we further demonstrated that hepatocyte SH3RF2 deficiency markedly deteriorates lipid accumulation in cultured hepatocytes and diet-induced NAFLD mice. Mechanistically, SH3RF2 directly binds to ATP citrate lyase, the primary enzyme promoting cytosolic acetyl-coenzyme A production, and promotes its K48-linked ubiquitination-dependent degradation. Consistently, acetyl-coenzyme A was significantly accumulated in Sh3rf2-knockout hepatocytes and livers compared with wild-type controls, leading to enhanced de novo lipogenesis, cholesterol production, and resultant lipid deposition. CONCLUSION: SH3RF2 depletion in hepatocytes is a critical aggravator for NAFLD progression and therefore represents a promising therapeutic target for related liver diseases.
引用
- Yang X, Sun D, Xiang H, et al. Hepatocyte SH3RF2 Deficiency Is a Key Aggravator for NAFLD. Hepatology. 2021. PMID: 33894019. doi:10.1002/hep.31863
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。